Avenir Corporation’s Adaptive Biotechnologies ADPT Stock Holding History

Avenir Corporation’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.61M	Sell	74,865 -1,500	-2%	-$23K	0.2%	33
2026 Q1	$1.06M	Hold	76,365	–	–	0.13%	39
2025 Q4	$1.24M	Hold	76,365	–	–	0.13%	36
2025 Q3	$1.14M	Hold	76,365	–	–	0.12%	38
2025 Q2	$890K	Hold	76,365	–	–	0.09%	43
2025 Q1	$567K	Hold	76,365	–	–	0.06%	48
2024 Q4	$458K	Hold	76,365	–	–	0.05%	51
2024 Q3	$391K	Hold	76,365	–	–	0.04%	54
2024 Q2	$276K	Buy	76,365 +10,000	+15%	+$31.7K	0.03%	60
2024 Q1	$213K	Hold	66,365	–	–	0.02%	64
2023 Q4	$325K	Buy	66,365 +35,800	+117%	+$163K	0.03%	56
2023 Q3	$167K	Hold	30,565	–	–	0.02%	59
2023 Q2	$205K	Sell	30,565 -85	-0.3%	-$632	0.02%	59
2023 Q1	$271K	Hold	30,650	–	–	0.03%	55
2022 Q4	$234K	Hold	30,650	–	–	0.02%	59
2022 Q3	$218K	Sell	30,650 -23,450	-43%	-$221K	0.02%	57
2022 Q2	$438K	Buy	54,100 +25,100	+87%	+$221K	0.04%	48
2022 Q1	$403K	Buy	29,000 +1,000	+4%	+$15.7K	0.03%	51
2021 Q4	$786K	Hold	28,000	–	–	0.06%	44
2021 Q3	$952K	Hold	28,000	–	–	0.08%	45
2021 Q2	$1.14M	Hold	28,000	–	–	0.09%	43
2021 Q1	$1.13M	Hold	28,000	–	–	0.1%	45
2020 Q4	$1.66M	Hold	28,000	–	–	0.16%	37
2020 Q3	$1.36M	Hold	28,000	–	–	0.14%	39
2020 Q2	$1.35M	Buy	+28,000	New	+$1.02M	0.15%	39

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Avenir Corporation's ADPT Position: Q2 2026 in Review

Avenir Corporation reduced its Adaptive Biotechnologies (ADPT) stake by 2% in Q2 2026, selling an estimated $23K and leaving 74,865 shares worth $1.61M. The position accounts for 0.2% of the portfolio, ranked #33.

Avenir Corporation first reported a position in ADPT in Q2 2020 and has held it in 25 quarters since. The position peaked at $1.66M in Q4 2020. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

Avenir Corporation held 74,865 shares of Adaptive Biotechnologies worth $1.61M as of Q2 2026.
Avenir Corporation sold 1,500 Adaptive Biotechnologies shares in Q2 2026, an estimated $23K.
Adaptive Biotechnologies made up 0.2% of Avenir Corporation's portfolio in Q2 2026, its #33 holding.
Avenir Corporation first reported a position in Adaptive Biotechnologies in Q2 2020 and has held it in 25 quarters since.
Avenir Corporation's Adaptive Biotechnologies position peaked at $1.66M in Q4 2020.
300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Avenir Corporation's 13F filing for Q2 2026, filed 13 Aug 2026.